Alithea Genomics Competitors and Similar CompaniesClear all

Alithea Genomics's competitors and similar companies include Formation Bio, APIM Therapeutics, Galapagos and Blueberry Therapeutics.

	Alithea Genomics Alithea Genomics is a biotech company that specializes in RNA sequencing and transcriptomics analysis.	Formation Bio Formation Bio (also known as Trialspark) is a technology-driven pharmaceutical company that specializes in clinical trials and drug development.	APIM Therapeutics APIM Therapeutics is a clinical-stage biotech company focusing on the development of treatments in the fields of oncology and inflammation.	Galapagos Galapagos is a biotechnology company.	Blueberry Therapeutics Blueberry Therapeutics is a company that offers nanopolymer drug delivery technology.
Founding Date	Founding Date 2020	Founding Date 2013	Founding Date 2010	Founding Date 1999	Founding Date 2011
Type	Type Private	Type Private	Type Subsidiary	Type Public	Type Private
Tags	Tags Technology biotech clinical research drug development	Tags Technology artificial intelligence biotech clinical research drug development healthtech platform	Tags Technology biotech clinical research drug development oncology	Tags Healthcare Technology biotech clinical research drug development	Tags Technology biotech clinical research drug development nanotech
Locations	Locations Epalinges, CH HQ Cossonay, CH	Locations New York, US HQ	Locations Trondheim, NO HQ Rissa, NO	Locations Mechelen, BE HQ Romainville, FR Leiden, NL Basel, CH Waltham, US	Locations Alderley Edge, GB HQ
Employees	Employees 336% increase	Employees 1775% increase	Employees 7	Employees 70437% decrease	Employees 3
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) €1.1b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods kr1.2m (FY, 2021)	Cost of goods €25.7m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit (kr1.2m) (FY, 2021)	Gross profit €1.2b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income (kr14.8m) (FY, 2021)	Net income €320.9m (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round $ 1m (almost 4 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 12.7m (almost 8 years ago)
Total funding raised	Total funding raised $ 1m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 3.7m	Total funding raised $ 12.7m